Top Markets
Coin of the day
Gencurix, Inc. Gencurix, Inc.

Gencurix, Inc.

229000
Rank in Stocks #28133
Gencurix Inc. provides diagnostic solutions in South Korea. Its products... Gencurix Inc. provides diagnostic solutions in South Korea. Its products include GenesWell BCT, a multigene diagnostic test for breast cancer; Droplex, a genetic test based on digital PCR platform; eDX, an early diagnosis for cancer with liquid biopsy; GenePro SARS-CoV-2 Test kit; GenoCTC, a circulating tumor cell isolator; and GenePro LAMP Cycler, a portable device for infectious disease detection. The company has a strategic alliance with Qiagen N.V. for the development of oncology assays for use on the QIAcuityDx platform. The company was founded in 2011 and is headquartered in Seoul, South Korea.
Share Price
$1.21
Market Cap
$28.43M
Change (1 day)
1.27%
Change (1 year)
6.29%
Country
KR
Trade Gencurix, Inc. (229000)

Category

Revenue for Gencurix, Inc. (229000)
Revenue in Aug 2026 TTM: 0
According to Gencurix, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Gencurix, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors